Deals

MicuRx Pharmaceuticals Licenses MRX‑23 ADC and STOPIN Platform to ClearideBio in Multi‑Asset Global Deal Worth Up to USD 973 Million
ADC / XDCClearideBio Therapeutics

MicuRx Pharmaceuticals Licenses MRX‑23 ADC and STOPIN Platform to ClearideBio in Multi‑Asset Global Deal Worth Up to USD 973 Million

Shanghai MicuRx Pharmaceuticals, Inc. (SHA: 688373) announced that it intends to enter into an MRX‑23 License Agreement and a Platform Technology Cooperation Agreement with ClearideBio Therapeutics AG, a Switzerland‑based biopharmaceutical…

Triastek Partners with Johnson & Johnson to Develop Novel Oral Medicines Using 3D Printing Pharmaceutical Technology – JJDC Makes Strategic Equity Investment

Triastek Partners with Johnson & Johnson to Develop Novel Oral Medicines Using 3D Printing Pharmaceutical Technology – JJDC Makes Strategic Equity Investment

Viatris to Acquire Pacira BioSciences for USD 1.65 Billion – Expanding Non‑Opioid Pain Portfolio with EXPAREL and ZILRETTA

Viatris to Acquire Pacira BioSciences for USD 1.65 Billion – Expanding Non‑Opioid Pain Portfolio with EXPAREL and ZILRETTA

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Zelgen Licenses ZG006 to AbbVie for $1.2 Billion in Milestones Ex-China
AbbVieCancer

Zelgen Licenses ZG006 to AbbVie for $1.2 Billion in Milestones Ex-China

Ribo Life Science Raises HK$1.6 Billion in Hong Kong IPO for siRNA Pipeline
HKG: 6938IPO

Ribo Life Science Raises HK$1.6 Billion in Hong Kong IPO for siRNA Pipeline

Broncus Medical Acquires Valgen Stake from Venus for $15 Million
Broncus MedicalHKG: 2216

Broncus Medical Acquires Valgen Stake from Venus for $15 Million

Edge Medical Raises HK$1.2 Billion in Hong Kong IPO as Surgical Robotics Leader
Edge MedicalHKG: 2675

Edge Medical Raises HK$1.2 Billion in Hong Kong IPO to Fund Surgical Robot Pipeline

Show More